Literature DB >> 21901421

The LOX-1 3'UTR188CT polymorphism and coronary artery disease in Turkish patients.

Ozlem Kurnaz1, A Başak Akadam-Teker, Hülya Yilmaz-Aydoğan, Atike Tekeli, Turgay Isbir.   

Abstract

In coronary artery disease (CAD), a potentially reversible factor leading to cardiac death is left ventricular hypertrophy (LVH). The 3'untranslated region (3'UTR) 188CT polymorphism of lectin-like oxidized low-density lipoproteins receptor-1 (LOX-1) gene has been associated with an increased risk for CAD. We aim to investigate, in a Turkish population, whether 3'UTR188CT variation could affect the development of LVH in CAD patients. In a population-based case-control study, we compared 83 cases with CAD and 99 healthy controls for this polymorphism. The LOX-1 3'UTR188CT genotypes were determined by PCR-RFLP technique. LOX-1 3'UTR188 TT genotype was associated with significantly increased systolic blood pressure (P = 0.047) and risk of LVH (P = 0.014, OR: 3.541) when compared with the C allele carriers. In addition, the TT genotype was positively associated with decreased levels of HDL-cholesterol in the control subjects (P = 0.031) and increased levels of VLDL-C in the patient group (P = 0.009). The LOX-1 3'UTR188CT gene polymorphism may predispose to the development of LVH in CAD patients, dependent on blood pressure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21901421     DOI: 10.1007/s11033-011-1222-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  23 in total

Review 1.  Receptors for oxidized low density lipoprotein.

Authors:  U P Steinbrecher
Journal:  Biochim Biophys Acta       Date:  1999-01-04

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment.

Authors:  L Puccetti; A L Pasqui; F Bruni; M Pastorelli; F Ciani; A Palazzuoli; A Pontani; A Ghezzi; A Auteri
Journal:  Int J Cardiol       Date:  2006-10-13       Impact factor: 4.164

Review 4.  Resistant hypertension and left ventricular hypertrophy: an overview.

Authors:  Cesare Cuspidi; Alvaro Vaccarella; Francesca Negri; Carla Sala
Journal:  J Am Soc Hypertens       Date:  2010 Nov-Dec

5.  Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction.

Authors:  R Mango; F Clementi; P Borgiani; G B Forleo; M Federici; G Contino; E Giardina; L Garza; I E Fahdi; R Lauro; J L Mehta; G Novelli; F Romeo
Journal:  J Med Genet       Date:  2003-12       Impact factor: 6.318

Review 6.  Established risk factors and coronary artery disease: the Framingham Study.

Authors:  P W Wilson
Journal:  Am J Hypertens       Date:  1994-07       Impact factor: 2.689

7.  Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease.

Authors:  Qi Chen; Steven E Reis; Candace Kammerer; Wendy Y Craig; Sue E LaPierre; Erin Luedecking Zimmer; Dennis M McNamara; Daniel F Pauly; Barry Sharaf; Richard Holubkov; C Noel Bairey Merz; George Sopko; Franklin Bontempo; M Ilyas Kamboh
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

8.  Variation in the human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) gene is associated with plasma soluble LOX-1 levels.

Authors:  Tina E Brinkley; Noriaki Kume; Hirokazu Mitsuoka; Michael D Brown; Dana A Phares; Robert E Ferrell; Toru Kita; James M Hagberg
Journal:  Exp Physiol       Date:  2008-05-09       Impact factor: 2.969

9.  Genotyping OLR1 gene: a genomic biomarker for cardiovascular diseases.

Authors:  Lucia Vecchione; Elisa Gargiul; Paola Borgiani; Irene Predazzi; Ruggiero Mango; Francesco Romeo; Mauro Magnani; Giuseppe Novelli
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2007-06

10.  Failure to replicate an association of SNPs in the oxidized LDL receptor gene (OLR1) with CAD.

Authors:  Joshua W Knowles; Themistocles L Assimes; Eric Boerwinkle; Stephen P Fortmann; Alan Go; Megan L Grove; Mark Hlatky; Carlos Iribarren; Jun Li; Richard Myers; Neil Risch; Stephen Sidney; Audrey Southwick; Kelly A Volcik; Thomas Quertermous
Journal:  BMC Med Genet       Date:  2008-04-02       Impact factor: 2.103

View more
  3 in total

Review 1.  LOX-1, a new marker of risk and prognosis in coronary artery disease?

Authors:  Valter Lubrano; Silvana Balzan
Journal:  Mol Cell Biochem       Date:  2013-08-11       Impact factor: 3.396

2.  Associations between Lectin-like, oxidized low-density lipoprotein receptor-1 G501C and 3'-UTR-C188T polymorphisms with coronary artery disease: a meta-analysis.

Authors:  Tian-Ying Feng; Hong-Wei Shan; Rui Lang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 3.  Needles in the genetic haystack of lipid disorders: single nucleotide polymorphisms in the microRNA regulome.

Authors:  Praveen Sethupathy
Journal:  J Lipid Res       Date:  2013-03-15       Impact factor: 5.922

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.